Biotech · Private company
Neurona Therapeutics
Track this companyFree. Adds Neurona Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- NRTX-1001Phase 3 · Mesial Temporal Lobe EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- Sham ComparatorPhase 3 · Mesial Temporal Lobe EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- NRTX-1001Phase 2 · Epilepsy, Temporal LobeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)PHASE1_PHASE2 · RECRUITING · started Nov 14, 2024ClinicalTrials.gov NCT06422923 · fetched Nov 12, 2026
- Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))PHASE3 · RECRUITING · started Jun 16, 2022ClinicalTrials.gov NCT05135091 · fetched Nov 12, 2026